News
Roche’s Tecentriq claims melanoma OK, but don’t expect a sal...
Roche’s checkpoint inhibitor Tecentriq has been cleared for another new use in the US – in melanoma – but could struggle to displace rival drugs from Bristol-Myers Squibb and M
